1. Connexin32 regulates expansion of liver cancer stem cells via the PI3K/Akt signaling pathway
   Hongyu Li et al, 2022, Oncology Reports CrossRef
2. Prominin‐like, a homolog of mammalian CD133, suppresses dilp6and TOR signaling to maintain body size and weight inDrosophila
   Huimei Zheng et al, 2019, The FASEB Journal CrossRef
3. Potential roles of stem cell marker genes in axon regeneration
   Jinyoung Lee et al, 2021, Experimental & Molecular Medicine CrossRef
4. Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
   Julia Pospieszna et al, 2023, International Journal of Molecular Sciences CrossRef
5. The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma
   Yan Xiang et al, 2016, Stem Cells International CrossRef
6. Salinomycin may inhibit the cancer stem‑like populations with increased chemoradioresistance that nasopharyngeal cancer tumorspheres contain
   Gong Zhang et al, 2018, Oncology Letters CrossRef
7. Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
   Ya‐Ping Liu et al, 2021, MedComm CrossRef
8. Cellular Origin of Hepatocellular Carcinoma
   null null et al, 2019, Hepatocellular Carcinoma CrossRef
9. Long Noncoding RNAs as Drivers of Acquired Chemoresistance in Hepatocellular Carcinoma
   Johanna K. DiStefano et al, 2020, The Chemical Biology of Long Noncoding RNAs CrossRef
10. Engineered extracellular vesicles mediated CRISPR-induced deficiency of IQGAP1/FOXM1 reverses sorafenib resistance in HCC by suppressing cancer stem cells
    Cong He et al, 2023, Journal of Nanobiotechnology CrossRef
11. Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity
    Zhuohong Li et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
12. Potential Role of CD133 Expression in the Susceptibility of Human Liver Cancer Stem-Like Cells to TRAIL
    Su-Hoon Lee et al, 2016, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
13. Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
    Germana Castelli et al, 2017, Cancers CrossRef
14. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
    Rui Han et al, 2021, Scientific Reports CrossRef
15. Phenethyl isothiocyanate inhibits CD133+/CD90+ liver cancer stem cells by modulation of microRNA‐214‐β‐catenin epigenome axis
    Yi C. Chu et al, 2023, Advances in Digestive Medicine CrossRef
16. Neurospora crassa is a potential source of anti-cancer agents against breast cancer
    Rui Han et al, 2022, Breast Cancer CrossRef
17. Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma
    Ewa Wolinska et al, 2021, Cancers CrossRef
18. NEAT1 Confers Radioresistance to Hepatocellular Carcinoma Cells by Inducing PINK1/Parkin-Mediated Mitophagy
    Hiroyuki Tsuchiya et al, 2022, International Journal of Molecular Sciences CrossRef
19. Liver Cancer: Stem and Progenitor Cells
    Arthur Zimmermann, 2017, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
20. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1
    Hee Ju et al, 2016, Toxicology Letters CrossRef
21. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro
    Yu Jin Kim et al, 2021, International Journal of Molecular Sciences CrossRef
22. Ral signaling pathway in health and cancer
    Adel Rezaei Moghadam et al, 2017, Cancer Medicine CrossRef
23. MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period
    Tarana Arman et al, 2021, Toxicology CrossRef
24. Cancer stem cell biomarkers and related signalling pathways
    Zhe Wang et al, 2024, Journal of Drug Targeting CrossRef
25. Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF
    Zhenzhen Chen et al, 2021, Journal of Clinical Investigation CrossRef
26. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
    Alice Nomura et al, 2015, Oncotarget CrossRef
27. Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
    Chunfeng Xie et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
28. Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells
    Haiyang Chen et al, 2013, Cancer Letters CrossRef
29. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells
    YAN-MIN LIU et al, 2015, Oncology Reports CrossRef
30. Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy
    Aleksandr Klinkovskij et al, 2023, Biomedicines CrossRef
31. Cancer stem cells: advances in knowledge and implications for cancer therapy
    Xianjing Chu et al, 2024, Signal Transduction and Targeted Therapy CrossRef
32. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells
    Sherien M. El-Daly et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
33. Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways
    Omar A. Ammar et al, 2022, Heliyon CrossRef
34. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide
    Jonathan L. Tso et al, 2015, Molecular Cancer CrossRef
35. PKHhigh cells within clonal human nephrospheres provide a purified adult renal stem cell population
    Silvia Bombelli et al, 2013, Stem Cell Research CrossRef
36. The stem cell marker Prom1 promotes axon regeneration by down-regulating cholesterol synthesis via Smad signaling
    Jinyoung Lee et al, 2020, Proceedings of the National Academy of Sciences CrossRef
37. Liver Cancer: Stem and Progenitor Cells
    Arthur Zimmermann, 2016, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
38. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma
    Ssu-Yin Yen et al, 2017, International Journal of Molecular Sciences CrossRef
39. Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133+ HepG2 liver cancer cells
    Changhao Fu et al, 2018, Oncology Letters CrossRef
40. Microvesicles – promising tiny players’ of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects
    Cong He et al, 2021, Pharmacological Research CrossRef
41. In Vitro Anticancer Effect of Gedunin on Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells
    Luxmiga Tharmarajah et al, 2017, BioMed Research International CrossRef
42. 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis
    Wipa Chantarawong et al, 2019, Marine Drugs CrossRef
43. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy
    Caecilia H C Sukowati et al, 2013, Expert Review of Gastroenterology & Hepatology CrossRef
44. Research progress and prospects of markers for liver cancer stem cells
    Cheng-Pei Zhu, 2015, World Journal of Gastroenterology CrossRef
45. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy
    Zahra Asadzadeh et al, 2021, Biomedicine & Pharmacotherapy CrossRef
46. The prominin-like Gene Expressed in a Subset of Dopaminergic Neurons Regulates Locomotion in Drosophila
    Tae Hoon Ryu et al, 2022, Molecules and Cells CrossRef